Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2020-11-06 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
公告本公司董事會通過109年第3季合併財務報告案
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1734 杏輝) reporting the board's approval of the consolidated financial report for the third quarter of fiscal year 109 (which corresponds to 2020 in the Gregorian calendar). It includes cumulative financial figures such as revenue, gross profit, net profit, earnings per share, total assets, liabilities, and equity as of the period end. The document is short (804 characters) and primarily serves as a notification of the board's approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or substantive analysis but summarizes key financial data. Therefore, it fits best as an Interim / Quarterly Report (IR) since it reports quarterly financial results with actual financial data, not merely an announcement of a report publication or a certification. Confidence is high due to the presence of detailed financial figures and the nature of the announcement.
2020-11-06 Chinese
109年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It lists the number of shares held, changes in holdings, and other related information. This type of disclosure is typical of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but the actual detailed insider shareholding data. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-10-15 Chinese
109年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related percentages. It focuses on insider shareholdings and their changes, which is typical of a Director's Dealing or insider share transaction report. There is no indication of financial results, earnings, or management discussion. The document is relatively short (3281 characters) and does not mention any report publication or voting results. Therefore, the document best fits the category of Director's Dealing (DIRS).
2020-10-15 Chinese
109年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (杏輝) providing information about fund loans and endorsement guarantees for the current and previous month, including cumulative balances and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or regulatory certification. The content is a regulatory announcement of financial status related to guarantees and loans, typical of a general regulatory filing rather than a full report or announcement of voting results, management changes, or capital updates. The document length is short (615 characters), and it does not indicate it is an announcement of a report publication. Therefore, the best fitting category is Regulatory Filings (RNS).
2020-10-12 Chinese
109年9月營業收入
Interim / Quarterly Report Classification · 95% confidence The document is a summary report of net operating revenue for a company named 杏輝 for the period 民國109年09月 (September 2020). It contains numerical financial data such as monthly and cumulative revenue figures, percentage changes, and notes on accounting standards (IFRS). The document is short (772 characters) and provides actual financial data rather than just an announcement or certification. It is not a full annual report but rather a periodic financial summary. Given the presence of substantive financial data for a specific period shorter than a full fiscal year, this fits the definition of an Interim / Quarterly Report (IR).
2020-10-12 Chinese
本公司受衛生福利部裁處案之說明
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (1734 杏輝) regarding a regulatory action by the Ministry of Health and Welfare related to product quality issues and corrective measures. It details the event, impact on revenue, penalties, and corrective actions. The document is short (1038 characters) and serves as a factual disclosure of a regulatory matter rather than a financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. It fits best under Regulatory Filings (RNS) as a general regulatory announcement about compliance and operational issues.
2020-10-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.